Captor Therapeutics Spolka Akcyjna (WSE:CTX)
65.80
-1.20 (-1.79%)
Oct 5, 2026, 12:39 PM CET
WSE:CTX Market Cap
WSE:CTX has a market cap or net worth of 425.68 million as of October 2, 2026. Its market cap has increased by 102.62% in one year.
Market Cap
425.68M
Enterprise Value
356.84M
Revenue
2.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
65.80
ChartMarket Cap Chart
Since April 19, 2021, WSE:CTX's market cap has decreased from 749.17M to 425.68M, a decrease of -43.18%. That is a compound annual growth rate of -9.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 425.68M | 6.94% |
| Dec 30, 2025 | 398.07M | 101.82% |
| Dec 30, 2024 | 197.24M | -57.12% |
| Dec 29, 2023 | 459.93M | -31.04% |
| Dec 30, 2022 | 666.90M | -10.15% |
| Dec 30, 2021 | 742.21M | -0.93% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 568.96M |
| Bioceltix | 406.62M |
| Ryvu Therapeutics | 361.14M |
| BIOTON | 326.71M |
| Synthaverse | 213.67M |
| Molecure | 145.87M |
| Mabion | 126.87M |
| Poltreg | 120.70M |